Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Neuritis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Diabetic Peripheral Neuropathy (DPN)
1.2.3 Chemotherapy-induced Peripheral Neuropathy (CIPN)
1.2.4 Idiopathic Peripheral Neuropathy (IPN)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peripheral Neuritis Treatment Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Neuritis Treatment Market Perspective (2018-2034)
2.2 Peripheral Neuritis Treatment Growth Trends by Region
2.2.1 Global Peripheral Neuritis Treatment Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Peripheral Neuritis Treatment Historic Market Size by Region (2018-2024)
2.2.3 Peripheral Neuritis Treatment Forecasted Market Size by Region (2024-2034)
2.3 Peripheral Neuritis Treatment Market Dynamics
2.3.1 Peripheral Neuritis Treatment Industry Trends
2.3.2 Peripheral Neuritis Treatment Market Drivers
2.3.3 Peripheral Neuritis Treatment Market Challenges
2.3.4 Peripheral Neuritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Neuritis Treatment Players by Revenue
3.1.1 Global Top Peripheral Neuritis Treatment Players by Revenue (2018-2024)
3.1.2 Global Peripheral Neuritis Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Peripheral Neuritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Neuritis Treatment Revenue
3.4 Global Peripheral Neuritis Treatment Market Concentration Ratio
3.4.1 Global Peripheral Neuritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Neuritis Treatment Revenue in 2022
3.5 Peripheral Neuritis Treatment Key Players Head office and Area Served
3.6 Key Players Peripheral Neuritis Treatment Product Solution and Service
3.7 Date of Enter into Peripheral Neuritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Neuritis Treatment Breakdown Data by Type
4.1 Global Peripheral Neuritis Treatment Historic Market Size by Type (2018-2024)
4.2 Global Peripheral Neuritis Treatment Forecasted Market Size by Type (2024-2034)
5 Peripheral Neuritis Treatment Breakdown Data by Application
5.1 Global Peripheral Neuritis Treatment Historic Market Size by Application (2018-2024)
5.2 Global Peripheral Neuritis Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Peripheral Neuritis Treatment Market Size (2018-2034)
6.2 North America Peripheral Neuritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Peripheral Neuritis Treatment Market Size by Country (2018-2024)
6.4 North America Peripheral Neuritis Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Neuritis Treatment Market Size (2018-2034)
7.2 Europe Peripheral Neuritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Peripheral Neuritis Treatment Market Size by Country (2018-2024)
7.4 Europe Peripheral Neuritis Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Neuritis Treatment Market Size (2018-2034)
8.2 Asia-Pacific Peripheral Neuritis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Neuritis Treatment Market Size (2018-2034)
9.2 Latin America Peripheral Neuritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Peripheral Neuritis Treatment Market Size by Country (2018-2024)
9.4 Latin America Peripheral Neuritis Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Neuritis Treatment Market Size (2018-2034)
10.2 Middle East & Africa Peripheral Neuritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Peripheral Neuritis Treatment Introduction
11.1.4 Pfizer Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Depomed
11.2.1 Depomed Company Detail
11.2.2 Depomed Business Overview
11.2.3 Depomed Peripheral Neuritis Treatment Introduction
11.2.4 Depomed Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.2.5 Depomed Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Peripheral Neuritis Treatment Introduction
11.3.4 Novartis Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.3.5 Novartis Recent Development
11.4 Biogen
11.4.1 Biogen Company Detail
11.4.2 Biogen Business Overview
11.4.3 Biogen Peripheral Neuritis Treatment Introduction
11.4.4 Biogen Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.4.5 Biogen Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Peripheral Neuritis Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Peripheral Neuritis Treatment Introduction
11.6.4 Sanofi Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.6.5 Sanofi Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Detail
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Peripheral Neuritis Treatment Introduction
11.7.4 Eli Lilly and Company Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.7.5 Eli Lilly and Company Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Peripheral Neuritis Treatment Introduction
11.8.4 Bristol-Myers Squibb Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Detail
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Peripheral Neuritis Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.9.5 Baxter Healthcare Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Peripheral Neuritis Treatment Introduction
11.10.4 Johnson & Johnson Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Detail
11.11.2 Teva Pharmaceuticals Business Overview
11.11.3 Teva Pharmaceuticals Peripheral Neuritis Treatment Introduction
11.11.4 Teva Pharmaceuticals Revenue in Peripheral Neuritis Treatment Business (2018-2024)
11.11.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peripheral Neuritis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Diabetic Peripheral Neuropathy (DPN)
Table 3. Key Players of Chemotherapy-induced Peripheral Neuropathy (CIPN)
Table 4. Key Players of Idiopathic Peripheral Neuropathy (IPN)
Table 5. Key Players of Others
Table 6. Global Peripheral Neuritis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Peripheral Neuritis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Peripheral Neuritis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Peripheral Neuritis Treatment Market Share by Region (2018-2024)
Table 10. Global Peripheral Neuritis Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Peripheral Neuritis Treatment Market Share by Region (2024-2034)
Table 12. Peripheral Neuritis Treatment Market Trends
Table 13. Peripheral Neuritis Treatment Market Drivers
Table 14. Peripheral Neuritis Treatment Market Challenges
Table 15. Peripheral Neuritis Treatment Market Restraints
Table 16. Global Peripheral Neuritis Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Peripheral Neuritis Treatment Market Share by Players (2018-2024)
Table 18. Global Top Peripheral Neuritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Neuritis Treatment as of 2022)
Table 19. Ranking of Global Top Peripheral Neuritis Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Peripheral Neuritis Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peripheral Neuritis Treatment Product Solution and Service
Table 23. Date of Enter into Peripheral Neuritis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peripheral Neuritis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2018-2024)
Table 27. Global Peripheral Neuritis Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Peripheral Neuritis Treatment Revenue Market Share by Type (2024-2034)
Table 29. Global Peripheral Neuritis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Peripheral Neuritis Treatment Revenue Market Share by Application (2018-2024)
Table 31. Global Peripheral Neuritis Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Peripheral Neuritis Treatment Revenue Market Share by Application (2024-2034)
Table 33. North America Peripheral Neuritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 34. North America Peripheral Neuritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Peripheral Neuritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Peripheral Neuritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. Europe Peripheral Neuritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Peripheral Neuritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Peripheral Neuritis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Peripheral Neuritis Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Peripheral Neuritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 43. Latin America Peripheral Neuritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Peripheral Neuritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Peripheral Neuritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 46. Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Peripheral Neuritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Peripheral Neuritis Treatment Product
Table 51. Pfizer Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Depomed Company Detail
Table 54. Depomed Business Overview
Table 55. Depomed Peripheral Neuritis Treatment Product
Table 56. Depomed Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 57. Depomed Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Peripheral Neuritis Treatment Product
Table 61. Novartis Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Biogen Company Detail
Table 64. Biogen Business Overview
Table 65. Biogen Peripheral Neuritis Treatment Product
Table 66. Biogen Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 67. Biogen Recent Development
Table 68. GlaxoSmithKline Company Detail
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Peripheral Neuritis Treatment Product
Table 71. GlaxoSmithKline Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Sanofi Company Detail
Table 74. Sanofi Business Overview
Table 75. Sanofi Peripheral Neuritis Treatment Product
Table 76. Sanofi Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Eli Lilly and Company Company Detail
Table 79. Eli Lilly and Company Business Overview
Table 80. Eli Lilly and Company Peripheral Neuritis Treatment Product
Table 81. Eli Lilly and Company Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 82. Eli Lilly and Company Recent Development
Table 83. Bristol-Myers Squibb Company Detail
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Peripheral Neuritis Treatment Product
Table 86. Bristol-Myers Squibb Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Baxter Healthcare Company Detail
Table 89. Baxter Healthcare Business Overview
Table 90. Baxter Healthcare Peripheral Neuritis Treatment Product
Table 91. Baxter Healthcare Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 92. Baxter Healthcare Recent Development
Table 93. Johnson & Johnson Company Detail
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Peripheral Neuritis Treatment Product
Table 96. Johnson & Johnson Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 97. Johnson & Johnson Recent Development
Table 98. Teva Pharmaceuticals Company Detail
Table 99. Teva Pharmaceuticals Business Overview
Table 100. Teva Pharmaceuticals Peripheral Neuritis Treatment Product
Table 101. Teva Pharmaceuticals Revenue in Peripheral Neuritis Treatment Business (2018-2024) & (US$ Million)
Table 102. Teva Pharmaceuticals Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Neuritis Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Peripheral Neuritis Treatment Market Share by Type: 2022 VS 2034
Figure 3. Diabetic Peripheral Neuropathy (DPN) Features
Figure 4. Chemotherapy-induced Peripheral Neuropathy (CIPN) Features
Figure 5. Idiopathic Peripheral Neuropathy (IPN) Features
Figure 6. Others Features
Figure 7. Global Peripheral Neuritis Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Peripheral Neuritis Treatment Market Share by Application: 2022 VS 2034
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Peripheral Neuritis Treatment Report Years Considered
Figure 13. Global Peripheral Neuritis Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Peripheral Neuritis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Peripheral Neuritis Treatment Market Share by Region: 2022 VS 2034
Figure 16. Global Peripheral Neuritis Treatment Market Share by Players in 2022
Figure 17. Global Top Peripheral Neuritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Neuritis Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Peripheral Neuritis Treatment Revenue in 2022
Figure 19. North America Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Peripheral Neuritis Treatment Market Share by Country (2018-2034)
Figure 21. United States Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Peripheral Neuritis Treatment Market Share by Country (2018-2034)
Figure 25. Germany Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Peripheral Neuritis Treatment Market Share by Region (2018-2034)
Figure 33. China Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Peripheral Neuritis Treatment Market Share by Country (2018-2034)
Figure 41. Mexico Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Peripheral Neuritis Treatment Market Share by Country (2018-2034)
Figure 45. Turkey Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Peripheral Neuritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 48. Depomed Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 49. Novartis Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 50. Biogen Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 52. Sanofi Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 55. Baxter Healthcare Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 56. Johnson & Johnson Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 57. Teva Pharmaceuticals Revenue Growth Rate in Peripheral Neuritis Treatment Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed